Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03020277
Other study ID # RC16_0185
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 3, 2018
Est. completion date June 3, 2019

Study information

Verified date January 2024
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective, longitudinal, exploratory, open study with a 6-month follow-up period to explore via a specific Smartphone© application the evolution of a child's behavior over 6 months and the (psychological and social) effects of these changes on the family.


Description:

This is a prospective, longitudinal, exploratory, open study with a 6-month follow-up period to assess the feasibility of using a Smartphone© application designed for parents of patients with ASD and to longitudinally collect data on the quality of life and anxiety of parents of children with ASD and the children's functional symptoms over multiple weeks under natural conditions. Population: The investigators propose to study individuals diagnosed with ASD based on National Health Authority (HAS) recommendations (on ADI-R diagnoses) from 3-16 years of age in the Pays de la Loire region. The investigators propose to include 100 families. The study is exploratory in nature; thus, randomizing patients is unnecessary. The investigators will include the first 100 families agreeing to participate in the study and meeting the inclusion criteria. All participants will be recruited from the Department of Child and Adolescent Psychiatry of University Hospital of Nantes and from the Regional Center for Autism (CRA des Pays de la Loire). Method: At the inclusion visit, parents will receive a code to download the app from the "application store" of their choice (depending on their Smartphone©) and sign an informed consent form. All type 1 data from the inclusion visit will be stored in an electronic database and in the Smartphone© application (during the setup process). This initial evaluation by the investigator will include the following type 1 data: - Sibling rank and marital status, - Lifestyle: rural or urban; single or multiple occupants of the chid's bedroom and housing type and surface, - Educational and teaching load and conditions (special education, inclusive education, partial or full time, etc.), and - The therapeutic management (speech therapy, psychomotor therapy, etc.). Type 2 data will be stored in the electronic database only: - Age at diagnosis, - Current drug treatments (name, starting date and dose), - Comorbidities (associated epilepsy, mental retardation and organic pathology), - Medical and psychiatric family antecedent (ATCD), - Original scores on the Autism Diagnostic Interview-Revised (ADI-R) and Autism Diagnostic Observation Schedule (ADOS) at the time of diagnosis, and - Scores on the French version of the Childhood Autism Rating Scale (CARS) (http://www.autisme.qc.ca) at baseline and at the end of the study.


Recruitment information / eligibility

Status Completed
Enrollment 65
Est. completion date June 3, 2019
Est. primary completion date June 3, 2019
Accepts healthy volunteers No
Gender All
Age group 3 Years to 16 Years
Eligibility Inclusion Criteria: - Having a child with an ASD diagnosis based on the International Classification of Diseases (ICD) 10 criteria. - Having at least one Smartphone© (iOS Apple or Android). - Signing the consent form for participation. Exclusion Criteria: - Having several children with an ASD diagnosis. - Having children living in more than two areas

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Ecological Momentary Assessment with Smartphone© Application
Filling of the application every 3 days for 6 months by subjects (parents of patients with ASD)

Locations

Country Name City State
France Angers CHU Angers
France Nantes CHU Nantes

Sponsors (2)

Lead Sponsor Collaborator
Nantes University Hospital Institut de Recherche en Santé Publique, France

Country where clinical trial is conducted

France, 

References & Publications (1)

Bonnot O, Bonneau D, Doudard A, Duverger P. Rationale and protocol for using a smartphone application to study autism spectrum disorders: SMARTAUTISM. BMJ Open. 2016 Nov 22;6(11):e012135. doi: 10.1136/bmjopen-2016-012135. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Filling rate of the application The primary outcome measure will be the filling rate (R) and the use of our application by the parents over six months. This number will be Automatically Generated by Application (AGA)
Number of fillings = R 60
6 months
Secondary child behavior with pairs Secondary outcome measure include data from the application, that will be also Automatically Generated by the Application, which is filled by the parents, predominantly using a VAS from 0 (no) to 10 (severe) to measure the following variables every 3 days for 6 months
Secondary child sleep disorders Secondary outcome measure include data from the application, that will be also Automatically Generated by the Application, which is filled by the parents, predominantly using a VAS from 0 (no) to 10 (severe) to measure the following variables every 3 days for 6 months
Secondary child eating disorders Secondary outcome measure include data from the application, that will be also Automatically Generated by the Application, which is filled by the parents, predominantly using a VAS from 0 (no) to 10 (severe) to measure the following variables every 3 days for 6 months
Secondary child general behavior Secondary outcome measure include data from the application, that will be also Automatically Generated by the Application, which is filled by the parents, predominantly using a Visual Analogic scale (VAS) from 0 (no) to 10 (severe) to measure the following variables every 3 days for 6 months
Secondary Visual Analogic scale quotation about parental self esteem Visual Analogic scale (1 is bad to 10 is perfect ) quotation about parental self esteem by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App) every 3 days for 6 months
Secondary Visual Analogic scale quotation about parental anxiety Visual Analogic scale (1 is bad to 10 is perfect) quotation about parental anxiety by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App) every 3 days for 6 months
Secondary Visual Analogic scale quotation about parental sleep Visual Analogic scale (1 is bad to 10 is perfect) quotation about parental sleep by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App) every 3 days for 6 months
Secondary Visual Analogic scale quotation about parental mood Visual Analogic scale (1 is bad to 10 is perfect) quotation about parental mood by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App) every 3 days for 6 months
Secondary Visual Analogic scale quotation about parental stress Visual Analogic scale (1 is bad to 10 is perfect) quotation about parental stress by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App) every 3 days for 6 months
Secondary Visual Analogic scale quotation about parental pain Visual Analogic scale (1 is bad to 10 is perfect) quotation about parental pain by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App) every 3 days for 6 months
Secondary Visual Analogic scale quotation about parental professional life Visual Analogic scale (1 is unsatisfactory to 10 is satisfactory) quotation about parental professional life by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App) every 3 days for 6 months
Secondary Visual Analogic scale quotation about parental personal life Visual Analogic scale (1 is unsatisfactory to 10 is satisfactory) quotation about parental personal life by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App) every 3 days for 6 months
Secondary Visual Analogic scale quotation about parental social life Visual Analogic scale (1 is unsatisfactory to 10 is satisfactory) quotation about parental social life by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App) every 3 days for 6 months
Secondary Visual Analogic scale quotation about parental support and resources Visual Analogic scale (1 is unsatisfactory to 10 is satisfactory) quotation about parental support and resources from third persons by participants as assessed by SMARTAUTISM Application V1 2017 (Registered App) every 3 days for 6 months
Secondary the duration of use every 3 days for 6 months
Secondary the time of use every 3 days for 6 months
Secondary rate of complete filling every 3 days for 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02625116 - ELENA Cohort: A Long-term Longitudinal Study in a Pediatric Sample With Autism Spectrum Disorders
Not yet recruiting NCT06381856 - Improving Participation of Autistic Children and Adolescents in the Habilitation Process
Recruiting NCT02280746 - Gluten for Autism Spectrum Disorders N/A
Completed NCT01945957 - Brain Imaging of Intranasal Oxytocin Treatment in Autism Phase 1
Completed NCT01661855 - A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD Phase 2
Completed NCT01694667 - Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder Phase 2
Completed NCT01780090 - Handheld Technology for Speech Development in Students With Autism N/A
Completed NCT01592747 - Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine Phase 2
Completed NCT01691066 - Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder N/A
Active, not recruiting NCT01417026 - Intranasal Oxytocin and Learning in Autism Phase 2
Enrolling by invitation NCT01364818 - Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment N/A
Completed NCT01695200 - Omega-3 Fatty Acids in Autism Spectrum Disorders Phase 4
Completed NCT02300597 - Internet-based Support for Young People With ADHD and Autism - a Controlled Study N/A
Completed NCT01675414 - Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD) N/A
Not yet recruiting NCT00695812 - The Development of Younger Siblings of Children With Autism Now at 10 Years of Age N/A
Recruiting NCT05910502 - Project AFECT (Autism Family Empowerment Coaching and Training Program) N/A
Completed NCT02081027 - Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders Early Phase 1
Completed NCT02797379 - The Development of a Psychoeducational Tool to Manage Anxiety in People With Autism Spectrum Disorders N/A
Terminated NCT01730079 - Near Infrared Spectroscopy in Children With Autism and ADHD
Completed NCT01603225 - Transcranial Direct Current Stimulation and Autism